Search hospitals > California > Fremont
Kaiser Permanente-Fremont
Claim this profileFremont, California 94538
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Stomach Cancer
182 reported clinical trials
6 medical researchers
Summary
Kaiser Permanente-Fremont is a medical facility located in Fremont, California. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Kaiser Permanente-Fremont is involved with conducting 182 clinical trials across 329 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Natalya Greyz-Yusupov.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
38 reported clinical trials
103 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo2 years of reported clinical research
Studies Skin Cancer
Studies Cutaneous Melanoma
22 reported clinical trials
52 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara3 years of reported clinical research
Studies Breast Cancer
Studies Prostate Cancer
22 reported clinical trials
63 drugs studied
Natalya Greyz-YusupovKaiser Permanente-Fresno5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
13 drugs studied
Clinical Trials running at Kaiser Permanente-Fremont
Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Esophageal cancer
Stomach Cancer
Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente-Fremont?
Kaiser Permanente-Fremont is a medical facility located in Fremont, California. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Kaiser Permanente-Fremont is involved with conducting 182 clinical trials across 329 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Natalya Greyz-Yusupov.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.